Get the latest public health information from CDC
Get the latest research information from NIH | Español
NIH staff guidance on coronavirus (NIH Only)
Combat COVID Website

OBSSR Connector Monthly Newsletter

The Office of Behavioral and Social Sciences Research (OBSSR) Connector Monthly Newsletter is a monthly e-newsletter featuring updates from OBSSR Director William T. Riley, Ph.D., information about behavioral and social sciences in the news, events and announcements, findings from recently published research, funding announcements, and other updates. The current newsletter is provided below.
Subscribe to receive the OBSSR Connector Monthly Newsletter.

October 15, 2020

Director's Voice

NIH Behavioral and Social Science COVID-19 Research Funding. Halfway through this 2020 Fiscal Year (FY), we experienced a global pandemic, SARS-CoV-2, that has thus far resulted in over 34 million cases (over 7 million in the US) and over one million deaths (over 200,000 in the US), disproportionately affecting those already experiencing health disparities (e.g., under-resourced minorities, poor, vulnerable). All of us, even those not infected, have experienced life disruptions unprecedented in our lifetimes.

NIH rapidly responded to the public health crisis and the research needs of the crisis. Development and evaluation of therapeutics and vaccines have occurred at a robust and rapid pace, combining and coordinating public and private sector resources through the ACTIV program. Complementing this is the RADx program to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.

Read Full Blog

spotlight icon

Research Spotlights

Findings from Recently Published Research

Achieving herd immunity to COVID-19 may not be a practical public health strategy

Achieving herd immunity to COVID-19 may not be a practical public health strategy

In response to COVID-19, affected countries have imposed a range of public health strategies to manage outbreaks. In a recent study funded by NIGMS, researchers use modeling techniques to assess the long-term potential of success using these approaches. Typically, these strategies have fallen into two categories – “suppression” and “mitigation.” Broadly speaking, the goal of the suppression strategy is to drastically reduce COVID-19 transmission rates and stop endogenous transmission in the target population, while the goal of the mitigation strategy is to achieve herd immunity by allowing the virus to spread through the population while mitigating disease burden as to not overwhelm the healthcare system.
Read More

Smartphone applications based on ‘acceptance and commitment therapy’ are effective for smoking cessation

Smartphone applications based on ‘acceptance and commitment therapy’ are effective for smoking cessation

Digital interventions through smartphone applications are intended to improve treatment barriers for cessation of cigarette smoking, the leading cause of early death and disability worldwide. Despite the availability of nearly 500 English-language smartphone applications to date, only 5 randomized trials have tested the efficacy of some of these applications on abstinence rates. A study funded by NCI compared the efficacy of two smartphone applications- a more typical smoking cessation treatment model based on the United States Clinical Practice Guidelines (USCPG) versus an alternative treatment model based on acceptance and commitment therapy (ACT).
Learn More

Insomnia Symptoms in the Transition from Childhood to Adolescence

Insomnia Symptoms in the Transition from Childhood to Adolescence

Sleep has garnered attention over the years for its relationship with health outcomes. Research supported by the NHLBI, NIMH, and NCATS sought to study the natural history of insomnia symptoms in children that were followed into adolescence to establish population-based rates to better understand the course of insomnia, as well as risk factors. In youth, falling asleep and/or staying asleep are one of the most common parent-reported insomnia symptoms; with a prevalence in childhood and adolescence of 20-25%. Prior research has yielded varying estimates of persistence rates of insomnia symptoms in youth that range from 0% over a 12-year period to 52% over a 4-year period. Due to this high variability in results, the researchers examined individual risk factors that contribute to the persistence and incidence of insomnia symptoms in youth.
Go There Now

In the Know

Events and Announcements

search icon

Funding Announcements

Recently Published FOAs

icon of computer

Protocol Template for Behavioral and Social Sciences Research

Resource for communicating the science, methods, and operations of a clinical trial

PHP Code Snippets Powered By :